TransMedics TMDX · NASDAQ
$71.60 +1.16% (+$0.82)
Summary
62 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 23 USD is left as net profit.
- Revenue grew by 86% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 23% this fiscal year.
What to watch
- It missed profit estimates 4 times in the last 8 quarters.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.2 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 88% a year over 5 years. Over the last 3 years it grew by 86% a year. For the next fiscal year analysts expect revenue to grow by 23%.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 41 USD
- Research and development 14 USD
- Sales and administration 33 USD
- Taxes and other -10 USD
- Net profit 23 USD
Net profit, industry median (Medical - Devices) 6.9 USD
Out of every 100 USD of revenue, 23 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 11.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $96.86 is 35% above today's price. 69% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 62%
- Service Revenue 38%
By region
- UNITED STATES 90%
- Other Countries 9.9%
Product brings in 62% of revenue. Service Revenue grew fastest, by 154% a year.
Segments in detail